ABBV-291

· AbbVie

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABBV-291, covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma [Phase 1]

See pricing